- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Reform to Reduce Resident Fatigue Does Not Improve Post-Surgical Outcomes, Study Finds
A study published in the Journal of the American College of Surgeons evaluated whether the reducing resident duty hours improved surgical outcomes of patients.
In 2011, the Accreditation Council for Graduate Medical Education (ACGME) implemented a reform to restrict the number of duty hours for residents, the hope being to reduce fatigue-related errors that could harm patients. A study published in the Journal of the American College of Surgeons evaluated whether the ACGME reform improved surgical outcomes of patients from 5 surgical specialties (neurosurgery, obstetrics/gynecology, orthopaedic surgery, urology, and vascular surgery).
The study authors obtained surgical data from teaching and non-teaching surgical hospitals, 1 year before and 2 years after the reform was implemented, and the clinical outcome assessed was death or serious morbidity wthin 30 days of the surgery. However, at least for the 2 year period post-reform, the authors failed to find any significant correlation between reduced hours of resident duty and the 2 clinical outcomes being assessed.
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
